Payment overview · 2025
General Payments
$16.24
1 reported records · 1 companies
Healthcare provider profile · identity verified
Benjamin Heyen, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · MARION, NC · NPI 1649621038
Verified facts
What the public records show
CMS Open Payments records show Benjamin Heyen, M.D. received $16.24 in general payments during 2025 across 1 reported records.
Insmed, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Insmed, Inc. | Unresolved — no canonical attribution shown | $16.24 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $16.24 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Arikayce Normalized: arikayce |
Drug | Insmed, Inc. | $16.24 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Lisinopril | Lisinopril | 413 | 111 |
| Atorvastatin Calcium | Atorvastatin Calcium | 390 | 112 |
| Amlodipine Besylate | Amlodipine Besylate | 339 | 108 |
| Gabapentin | Gabapentin | 301 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 282 | 82 |
| Pantoprazole Sodium | Pantoprazole Sodium | 265 | 76 |
| Omeprazole | Omeprazole | 248 | 64 |
| Metformin Hcl | Metformin Hcl | 242 | 58 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 221 | 57 |
| Hydrochlorothiazide | Hydrochlorothiazide | 220 | 63 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 214 | 60 |
| Trazodone Hcl | Trazodone Hcl | 207 | 59 |
| Losartan Potassium | Losartan Potassium | 187 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 149 | 46 |
| Simvastatin | Simvastatin | 139 | 33 |
| Furosemide | Furosemide | 129 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 126 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 125 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 121 | 32 |
| Eliquis | Apixaban | 121 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 121 | 36 |
| Buspirone Hcl | Buspirone Hcl | 120 | 30 |
| Sertraline Hcl | Sertraline Hcl | 104 | 32 |
| Ropinirole Hcl | Ropinirole Hcl | 92 | 22 |
| Allopurinol | Allopurinol | 91 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 91 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 89 | 23 |
| Ozempic | Semaglutide | 87 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 84 | 22 |
| Metformin Hcl Er | Metformin Hcl | 83 | 23 |
| Carvedilol | Carvedilol | 73 | 19 |
| Montelukast Sodium | Montelukast Sodium | 70 | 25 |
| Spironolactone | Spironolactone | 70 | 24 |
| Celecoxib | Celecoxib | 62 | 14 |
| Tramadol Hcl | Tramadol Hcl | 61 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 59 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 57 | 14 |
| Meloxicam | Meloxicam | 56 | 21 |
| Mirtazapine | Mirtazapine | 56 | 18 |
| Pregabalin | Pregabalin | 56 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 56 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 55 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 55 | 17 |
| Ventolin Hfa | Albuterol Sulfate | 54 | 11 |
| Jardiance | Empagliflozin | 51 | 14 |
| Baclofen | Baclofen | 50 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 50 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 48 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 47 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 45 | 13 |
| Potassium Chloride | Potassium Chloride | 45 | 17 |
| Meclizine Hcl | Meclizine Hcl | 44 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 42 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 41 | 12 |
| Finasteride | Finasteride | 40 | 14 |
| Bupropion Xl | Bupropion Hcl | 37 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 11 |
| Prednisone | Prednisone | 37 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | 12 |
| Atenolol | Atenolol | 35 | 12 |
| Famotidine | Famotidine | 35 | 14 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | 12 |
| Aripiprazole | Aripiprazole | 34 | suppressed |
| Azithromycin | Azithromycin | 34 | 30 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 33 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 33 | suppressed |
| Clotrimazole | Clotrimazole | 32 | suppressed |
| Mounjaro | Tirzepatide | 31 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 31 | suppressed |
| Clonazepam | Clonazepam | 30 | suppressed |
| Ibuprofen | Ibuprofen | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 26 | suppressed |
| Levetiracetam | Levetiracetam | 25 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 25 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 22 |
| Diazepam | Diazepam | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Lovastatin | Lovastatin | 22 | suppressed |
| Glipizide | Glipizide | 21 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 21 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | 12 |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 20 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 15 |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Alprazolam | Alprazolam | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Premarin | Estrogens, Conjugated | 16 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Rybelsus | Semaglutide | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Edarbyclor | Azilsartan Med/Chlorthalidone | 12 | suppressed |
| Eletriptan Hbr | Eletriptan Hydrobromide | 12 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Lamotrigine Er | Lamotrigine | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.24 · 1 records | Insmed, Inc. | Arikayce | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error